✦ LIBER ✦

Randomized phase III trial of chemoimmunotherapy in patients with previously untreated stages III and IV suboptimal disease ovarian cancer: A Southwest Oncology Group study

✍ Scribed by David S. Alberts; Nancy Mason-Liddil; Robert V. O'Toole; Thomas M. Abbott; Richard Kronmal; Robert D. Hilgers; Earl A. Surwit; Harmon J. Eyre; Laurence H. Baker

Book ID: 119053244
Publisher: Elsevier Science
Year: 1989
Tongue: English
Weight: 763 KB
Volume: 32
Category: Article
ISSN: 0090-8258
DOI: 10.1016/0090-8258(89)90841-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized phase III trial of chemoimmun

Randomized phase III trial of chemoimmunotherapy in patients with previously untreated stage III, optimal disease ovarian cancer: A Southwest Oncology Group study

✍ David S. Alberts; Nancy Mason-Liddil; Robert V. O'Toole; Thomas M. Abbott; Richa 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 593 KB

Phase II trial of vinblastine in previou

Phase II trial of vinblastine in previously treated patients with ovarian cancer: A Southwest Oncology Group study

✍ E.A. Surwit; D.S. Alberts; R.V. O'Toole; V. Graham; E.V. Hannigan; R.L. Stephens 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 386 KB

Phase II trial of amonafide in previousl

Phase II trial of amonafide in previously treated patients with advanced ovarian cancer: A Southwest Oncology Group study

✍ Holly H. Gallion; P.Y. Liu; David E. Alberts; Robert V. O'Toole; Janet O'Sulliva 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 320 KB

A randomized trial of cyclophosphamide,

A randomized trial of cyclophosphamide, doxorubicin, and cisplatin with or without bacillus Calmette-Guerin in patients with suboptimal stage III and IV ovarian cancer: A Gynecologic Oncology Group Study

✍ William T. Creasman; George A. Omura; Mark F. Brady; Edgardo Yordan; Philip J. D 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 488 KB

A randomized trial of cyclophosphamide,

A randomized trial of cyclophosphamide, doxorubicin, and cisplatin with or without bacillus Calmette-Guerin in patients with suboptimal stage III and IV ovarian cancer: A gynecologic oncology group study

✍ W.T. Creasman; G.A. Omura; M.F. Brady; E. Yordan; P.J. DiSaia; J. Beecham 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 138 KB

Analysis of patient age as an independen

Analysis of patient age as an independent prognostic factor for survival in a phase III study of cisplatin–cyclophosphamide versus carboplatin–cyclophosphamide in stages III (suboptimal) and IV ovarian cancer: A southwest oncology group study

✍ David S. Alberts; Steve Dahlberg; Stephanie J. Green; Dava Garcia; Edward V. Han 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 888 KB